HLA class II molecules present antigenic peptides to the T cell receptor of
CD4+ T lymphocytes and interact with CD4 during the antigen recognition pr
ocess. A major CD4 binding site encompassing amino acids (aa) 134-148 in th
e beta 2 domain of HLA-DR has been previously identified and residues locat
ed within the alpha 2 subunit of murine MHC class II I-A(d) molecules have
been shown to contribute to CD4-class II interaction. To characterize the a
lpha 2 region of HLA-DR molecules involved in the binding of CD4, we have s
ynthesized overlapping linear and cyclic peptides derived from a region enc
ompassing aa 121-143. We demonstrate that two linear peptides (aa 124-138 a
nd 130-143) and a cyclic one (aa 121-138) specifically bind to CD4-sepharos
e affinity columns. Although cyclic analogues exhibit more ordered populati
ons as detected by circular dichroism measurements, cyclization did not imp
rove the activity of some peptides. Peptide sequence positioning in HLA-DR1
dimer model indicates that alpha 2 residues 124 to 136 form a solvent-expo
sed loop which faces the beta 2 loop delimited by residues 134-148. These d
ata suggest that one CD4 molecule contacts both alpha 2 and beta 2 loops of
the HLA-DR homodimer. Human Immunology 60, 273-281 (1999). (C) American So
ciety for Histocompatibility and Immunogenetics, 1999 Published by Elsevier
Science Inc.